动脉期CT影像组学无创预测胰腺实性假乳头状肿瘤Ki-67增殖指数
回顾性分析92例病理确诊胰腺实性假乳头状肿瘤患者,从动脉期螺旋CT提取影像组学特征构建CT评分并用深度学习模型预测Ki-67高表达(>3%),训练队列中最佳模型AUC达0.946,CT评分与形态学特征为关键预测因子。
要点
- 动脉期CT影像组学CT评分联合形态学特征有助于无创预测胰腺实性假乳头状肿瘤Ki-67增殖水平。
- 研究构建的深度学习模型在训练队列中预测Ki-67高表达的最佳AUC达0.946。
- CT评分与形态学特征是预测Ki-67水平的关键影像组学特征。
核心结论
- 基于动脉期CT图像的深度学习影像组学模型可预测胰腺实性假乳头状肿瘤患者Ki-67水平,CT评分与形态学特征为关键预测因子,该无创方法可能有助于指导个体化术前治疗策略。
研究设计与样本
- 回顾性分析2015年6月至2023年6月两家医院病理确诊的胰腺实性假乳头状肿瘤患者92例(宁波市医疗中心李惠利医院n=64,台州市中心医院n=28),训练队列n=64、验证队列n=28,从动脉期螺旋CT图像用PyRadiomics提取影像组学特征。
关键影像表现/征象
- 通过LASSO回归交叉验证筛选出7个关键影像组学特征并计算CT评分(CTscore)。
- 深度学习模型结合人口学信息与CT评分后准确性提高,形态学(Morphology)与CT评分对预测准确性贡献显著。
诊断标准与关键数值
- 以Ki-67阳性率>3%定义为高增殖水平。
- 最佳模型(包括GBM与深度学习算法)在训练队列中预测Ki-67高表达的AUC最高达0.946。
临床应用与阅片要点
- 阅片时可关注动脉期CT提取的影像组学CT评分及形态学特征,用于无创评估胰腺实性假乳头状肿瘤Ki-67增殖水平。
- 作者认为该无创方法可能有助于指导个体化术前治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: This study aimed to preoperatively predict Ki-67 proliferation levels in patients with pancreatic solid pseudopapillary neoplasm (pSPN) using radiomics features extracted from arterial phase helical CT images.
METHODS: We retrospectively analyzed 92 patients (Ningbo Medical Center Lihuili Hospital: n = 64, Taizhou Central Hospital: n = 28) with pathologically confirmed pSPN from June 2015 to June 2023. Ki-67 positivity > 3% was considered high. Radiomics features were extracted using PyRadiomics, with patients from training cohort (n = 64) and validation cohort (n = 28). A radiomics signature was constructed, and a CT radiomics score (CTscore) was calculated. Deep learning models were employed for prediction, with early stopping to prevent overfitting.
RESULTS: Seven key radiomics features were selected via LASSO regression with cross-validation. The deep learning model demonstrated improved accuracy with demographics and CTscore, with key features such as Morphology and CTscore contributing significantly to predictive accuracy. The best-performing models, including GBM and deep learning algorithms, achieved high predictive performance with an AUC of up to 0.946 in the training cohort.
CONCLUSIONS: We developed a robust deep learning-based radiomics model using arterial phase CT images to predict Ki-67 levels in pSPN patients, identifying CTscore and Morphology as key predictors. This non-invasive approach has potential utility in guiding personalized preoperative treatment strategies.
CLINICAL TRIAL NUMBER: Not applicable.
引用
- Liu J, Wu H, Ren D, et al. Arterial phase CT radiomics for non-invasive prediction of Ki-67 proliferation index in pancreatic solid pseudopapillary neoplasms. Abdom Radiol (NY). 2025. PMID: 40178588. doi:10.1007/s00261-025-04921-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。